|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.68 CHF | +2.78% |
|
+2.25% | +25.75% |
| May. 17 | Moody’s Upgrades Alcon on Strong Financial Performance | MT |
| May. 15 | Stifel Adjusts Price Target on Alcon to $100 From $95, Maintains Buy Rating | MT |
Novartis is replacing the CEO of Alcon unit as part of a broad restructuring caused by falling sales. The company reported that Mike Ball, will replace Jeff George at the helm of Alcon on Feb. 1, 2016.
George is leaving the company.
| 1st Jan change | Capi. | |
|---|---|---|
| +25.75% | 43.67B | |
| +14.92% | 103B | |
| +2.27% | 19.23B | |
| -15.77% | 2.36B | |
| +19.86% | 2.01B | |
| +28.88% | 1.23B | |
| -35.02% | 755M | |
| -5.96% | 683M | |
| -45.13% | 666M | |
| +24.65% | 501M |
ALCON INC. 
